Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: DRIO

DarioHealth Corp.

Healthcare | Medical - Diagnostics & Research

No licensed closing price on file for DRIO. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$10.12

DarioHealth Corp. (NASDAQ: DRIO) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-21 02:48 UTC.

What DarioHealth Corp. does

Dario is a vertically integrated health intelligence platform that combines FDA-cleared connected hardware devices, artificial intelligence, and behavior change coaching to address chronic disease management and mental health. The company operates across five elements of whole-person health: physical health, mental health, social and environmental factors, individualized care, and integration of clinical services. Dario serves four primary market segments including direct-to-consumer channels in the U.S.

Summarized from DarioHealth Corp.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (FY2025)$10.12
Return on equity-61.41%
Debt/equity0.56

Revenue, margins & earnings

FY2021: net loss $77M on revenue $21M$21MFY2021FY2022: net loss $62M on revenue $28M$28MFY2022FY2023: net loss $59M on revenue $20M$20MFY2023FY2024: net loss $43M on revenue $27M$27MFY2024FY2025: net loss $42M on revenue $22M$22MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-28
  • 2026-09-28DirectorAward62,000—
  • 2026-09-28Chief Executive OfficerConversion579$11.1K
  • 2026-09-28DirectorAward28,000—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does DarioHealth Corp. do?

Dario is a vertically integrated health intelligence platform that combines FDA-cleared connected hardware devices, artificial intelligence, and behavior change coaching to address chronic disease management and mental health.

When did DRIO last file with the SEC?

DarioHealth Corp.'s most recent SEC filing on record is a 8-K filed 2026-09-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 02:48 UTC. This page is also available as JSON at /api/data?ticker=DRIO and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for DRIO and 5,000+ tickers.

Create a free account — keep DRIO
For your agent
GET /api/data?ticker=DRIO

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt